FDA Approves Gocovri (amantadine) for the Treatment of Dyskinesia in Parkinsons Disease Patients
EMERYVILLE, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (
FDA Approves Besponsa
FDA Approves Besponsa (inotuzumab ozogamicin) for Relapsed or Refractory Acute Lymphoblastic Leukemia
FRIDAY, Aug. 18, 2017 -- Researchers say one dose of cholera vaccine appears to provide about the same protection as the standard two doses, at least for the first six months.
They also found that cholera vaccines are highly effective in adults but les
FRIDAY, Aug. 11, 2017 -- Scientists experimenting with the marijuana compound cannabidiol as an epilepsy treatment must evaluate any interactions with other anti-seizure drugs patients are taking, researchers report.
The new research from the Universit
FRIDAY, Aug. 11, 2017 -- Adults whove been hospitalized with pneumonia or sepsis have a higher risk of heart disease, a new European study reports.
Researchers examined data from nearly 237,000 Swedish men. They were followed from age 18 into middle ag
FDA Approves Vyxeos (daunorubicin and cytarabine) Liposome for Injection for Certain Types of Poor-Prognosis Acute Myeloid Leukemia